Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures



Public Access Version Available on: June 01, 2024, 12:00 AM
Please check back on the date listed above.
  • English

  • Details:

    • Alternative Title:
      Am J Prev Med
    • Description:
      Introduction:

      Emergency department (ED) visits and hospitalizations for unsupervised medication exposures among young children increased in the early 2000s. Prevention efforts were initiated in response.

      Methods:

      Nationally-representative data from the National Electronic Injury Surveillance System–Cooperative Adverse Drug Event Surveillance project collected from 2009-2020 were analyzed in 2022 to assess overall and medication-specific trends in ED visits for unsupervised exposures among children aged ≤5 years.

      Results:

      From 2009-2020, there were an estimated 677,968 (95% CI, 550,089-805,846) ED visits for unsupervised medication exposures among children aged ≤5 years in the United States. Most visits involved children aged 1-2 years (2009-2012 [70.3%]; 2017-2020 [67.4%]), and nearly one-half involved prescription solid medications (2009-2012 [49.4%]; 2017-2020 [48.1%]). The largest declines in estimated numbers of annual visits from 2009-2012 to 2017-2020 were for exposures involving prescription solid benzodiazepines (−2,636 visits; −72.0%) and opioids (−2,596 visits; −53.6%), and over-the-counter liquid cough and cold medications (−1,954 visits; −71.6%) and acetaminophen (−1,418 visits; −53.4%). The estimated number of annual visits increased for exposures involving over-the-counter solid herbals/alternative remedies (+1,028 visits; +65.6%), with the largest increase for melatonin exposures (+1,440 visits; +421.1%). Overall, the estimated number of visits for unsupervised medication exposures decreased from 66,416 in 2009 to 36,564 in 2020 (annual percentage change [APC] −6.0%). Emergent hospitalizations for unsupervised exposures also declined (APC −4.5%).

      Conclusions:

      Declines in estimated ED visits and hospitalizations for unsupervised medication exposures from 2009-2020 coincided with renewed prevention efforts. Targeted approaches may be needed to achieve continued declines in unsupervised medication exposures among young children.

    • Pubmed ID:
      37210158
    • Pubmed Central ID:
      PMC10935594
    • Document Type:
    • Collection(s):
    • Main Document Checksum:
    • File Type:
    • Supporting Files:
      No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov